Aim and Scope: Therapeutic monoclonal antibodies have become one of the most important areas in the modern pharmaceutical industry, with more than $52B in value and year-on-year growth currently leading all therapeutic approaches in the industry. Therapeutic monoclonal antibody leads can be discovered from phage, bacterial, yeast, mammalian cell, or in vitro display libraries, from immune compe...

Antibody drug conjugates (ADC) are an emerging class of pharmaceuticals consisting cytotoxic agents covalently attached to antibody designed target a specific cancer cell surface molecule followed by internalization and intracellular release payload exhibit its anticancer activity. Targeted delivery variety cells has been demonstrated have significant enhancement in clinical efficacy dramatic r...

*Author for correspondence: [email protected] Cancer is one leading cause of mortality that is associated with genetic background or environmental toxin [1]. Multiple anti-cancer therapies have been developed and applied clinically such as surgery, chemotherapy, radiotherapy, therapeutic antibody, small molecule, Antibody-Drug Conjugate (ADC), cellular immunotherapy, chemoimmunotherapy, and radioimm...